Abstract
A PtIV prodrug needs to be reduced to PtII by a biomolecule in order to show efficacy. Among biomolecules, those containing an l-Cys residue have the highest potential to be involved in reduction. Tautomerisation from HSCH2CH(NH3+)CO2− to the unusual zwitterion form −SCH2CH(NH3+)CO2H is the prerequisite for l-Cys to become a potent reductant at a low pH.
| Original language | English |
|---|---|
| Pages (from-to) | 10491-10494 |
| Number of pages | 4 |
| Journal | Chemical Communications |
| Volume | 54 |
| Issue number | 74 |
| DOIs | |
| Publication status | Published - 2018 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Reduction of a platinum(iv) prodrug model by sulfur containing biological reductants: computational mechanistic elucidation'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver